Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Association of High Levels of Free Light Chain and the Presence of Igh Translocations in Multiple Myeloma and Prognostic Implications.

Shaji Kumar, Lijun Zhang, Angela Dispenzieri, Scott Van Wier, Jerry Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kim Henderson, Arthur Bradwell, Robert Kyle, Philip Greipp, S. Vincent Rajkumar, Rafael Fonseca

Blood (2008) 112 (11): 1677.

https://doi.org/10.1182/blood.V112.11.1677.1677

Published: 2008

Journal Articles

Appraisal of immunoglobulin free light chain as a marker of response

Angela Dispenzieri, Lijun Zhang, Jerry A. Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kimberly Henderson, Robert A. Kyle, Martin M. Oken, Arthur R. Bradwell, Philip R. Greipp

Blood (2008) 111 (10): 4908–4915.

https://doi.org/10.1182/blood-2008-02-138602

Published: 2008

Journal Articles

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Blood (2006) 108 (10): 3458–3464.

https://doi.org/10.1182/blood-2006-04-015909

Published: 2006

Journal Articles

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Natalia Gonzalez-Paz, Wee J. Chng, Rebecca F. McClure, Emily Blood, Martin M. Oken, Brian Van Ness, C. David James, Paul J. Kurtin, Kimberly Henderson, Gregory J. Ahmann, Morie Gertz, Martha Lacy, Angela Dispenzieri, Philip R. Greipp, Rafael Fonseca

Blood (2006) 109 (3): 1228–1232.

https://doi.org/10.1182/blood-2006-05-024661

Published: 2006

Journal Articles

A Phase II Study of PS-341 for Patients with High Risk, Newly Diagnosed Multiple Myeloma: A Trial of the Eastern Cooperative Oncology Group (E2A02).

Angela Dispenzieri, MD, Emily Blood, MS, David Vesole, MD, Rafael Fonseca, MD, Natalie Callander, MD, Philip R. Greipp, MD

Blood (2005) 106 (11): 2546.

https://doi.org/10.1182/blood.V106.11.2546.2546

Published: 2005

Journal Articles

Comparison of Myeloma Cell Gene Expression Profiles Pre and Post Thalidomide - Dexamethasone Therapy Provides Insight into Potential Mechanisms.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica Haug, Michael Kline, PhD, Emily Blood, MS, Wee Joo Chng, John A. Lust, MD, Leif Bergsagel, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 3480.

https://doi.org/10.1182/blood.V106.11.3480.3480

Published: 2005

Journal Articles

SNP Genotypes as Prognostic Factors Associated with Staging in Myeloma: The First Combined SNP Association Analysis of SWOG, ECOG, and MRC Clinical Trials from the Bank on a Cure.

Brian Van Ness, John Crowley, Emily Blood, Erik Rasmussen, Christine Ramos, Suzanne Grindle, Gareth Morgan, David Johnson, Antje Hoering, Philip Greipp, Bart Barlogie, Brian Durie

Blood (2005) 106 (11): 3489.

https://doi.org/10.1182/blood.V106.11.3489.3489

Published: 2005

Journal Articles

Incidence, Outcomes, and SNP Genotypes Show Different Ethnic Association in Patients with Myeloma, Assessed in SWOG and ECOG Clinical Trials S9321 and E9486: From the Bank on a Cure.

Brian Van Ness, John Crowley, Christine Ramos, Suzanne Grindle, Erik Rasmussen, Emily Blood, Antje Hoering, Bart Barlogie, Philip Greipp, Brian Durie

Blood (2005) 106 (11): 506.

https://doi.org/10.1182/blood.V106.11.506.506

Published: 2005

Journal Articles

Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM).

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Rafael Santana-Davila, MD, Syed Jalal, PhD, Rhett Ketterling, MD, Peter Leif Bergsagel, MD, Marta Chesi, PhD, Mike Trendle, MD, Martin Oken, MD, Emily Blood, Kim Henderson, Robert Kyle, MD, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1539.

https://doi.org/10.1182/blood.V106.11.1539.1539

Published: 2005

Journal Articles

Inherited Genetic Variation and the Risk of Developing Venous Thrombosis with Thalidomide Treatment in Myeloma Patients.

David C. Johnson, BSc, Suzanne Grindle, BS, Faith Davies, MD, David Gonzalez, PhD, Christine Ramos, PhD, Kim Hawkins, MSc, Suzanne Bell, PhD, Heather Kesby, BSc, S. Vincent Rajkumar, MD, Erik Rassmusen, PhD, John Crowley, PhD, Emily Blood, PhD, J. Anthony Child, MD, Brian G.M. Durie, MD, Brian G. Van Ness, PhD, Gareth J. Morgan, MDPhD

Blood (2005) 106 (11): 1624.

https://doi.org/10.1182/blood.V106.11.1624.1624

Published: 2005

Journal Articles

Comparison of Newly Diagnosed and Relapsed Refractory Multiple Myeloma Using Transcriptional Profiling of Myeloma Cells.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica L. Haug, Michael Kline, PhD, Wee Joo Chng, Emily Blood, MS, John A. Lust, MD, PhD, Leif Bergsagel, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 1555.

https://doi.org/10.1182/blood.V106.11.1555.1555

Published: 2005

Journal Articles

Gene Expression Profiling of Myeloma Cells at Diagnosis Can Predict Response to Therapy with Thalidomide and Dexamethasone Combination.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica Haug, MD, Michael Kline, PhD, Wee Joo Chng, Emily Blood, MS, Leif Bergsagel, MD, John A. Lust, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 508.

https://doi.org/10.1182/blood.V106.11.508.508

Published: 2005

Journal Articles

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS

Wee Joo Chng, Scott A. Van Wier, Gregory J. Ahmann, Jerry M. Winkler, Syed M. Jalal, Peter Leif Bergsagel, Marta Chesi, Mike C. Trendle, Martin M. Oken, Emily Blood, Kim Henderson, Rafael Santana-Dávila, Robert A. Kyle, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Philip R. Greipp, Rafael Fonseca

Blood (2005) 106 (6): 2156–2161.

https://doi.org/10.1182/blood-2005-02-0761

Published: 2005

Journal Articles

Prognostic Value of Syndecan-1 in Multiple Myeloma and its Relationship with Other Prognostic Factors.

Shaji Kumar, MD, Emily Blood, Martin M. Oken, MD, Philip R. Greipp, MD

Blood (2004) 104 (11): 2402.

https://doi.org/10.1182/blood.V104.11.2402.2402

Published: 2004

Journal Articles

Thalidomide Plus Dexamethasone Versus Dexamethasone Alone in Newly Diagnosed Multiple Myeloma (E1A00): Results of a Phase III Trial Coordinated by the Eastern Cooperative Oncology Group.

S. Vincent Rajkumar, MD, Emily Blood, David H. Vesole, MD, PhD, Robert Shepard, MD, Philip R. Greipp, MD

Blood (2004) 104 (11): 205.

https://doi.org/10.1182/blood.V104.11.205.205

Published: 2004

Journal Articles

Associations of DNA Repair Gene Polymorphisms in XRCC1 and ERCC2 with Clinical Outcome in ECOG Trial E9486.

Brian Van Ness, Ph.D., Emily Blood, Ph.D., Philip Greipp, M.D., Neil Kay, M.D., Vincent Rajkumar, M.D., Robert Kyle, M.D., Martin Oken, M.D., Rafael Fonseca, M.D., Fangyi Zhao, Ph.D.

Blood (2004) 104 (11): 1475.

https://doi.org/10.1182/blood.V104.11.1475.1475

Published: 2004

Journal Articles

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

Rafael Fonseca, Carina S. Debes-Marun, Elisa B. Picken, Gordon W. Dewald, Sandra C. Bryant, Jerry M. Winkler, Emily Blood, Martin M. Oken, Rafael Santana-Dávila, Natalia González-Paz, Robert A. Kyle, Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Philip R. Greipp

Blood (2003) 102 (7): 2562–2567.

https://doi.org/10.1182/blood-2003-02-0493

Published: 2003

Journal Articles

Clinical and biologic implications of recurrent genomic aberrations in myeloma

Rafael Fonseca, Emily Blood, Montserrat Rue, David Harrington, Martin M. Oken, Robert A. Kyle, Gordon W. Dewald, Brian Van Ness, Scott A. Van Wier, Kimberly J. Henderson, Richard J. Bailey, Philip R. Greipp

Blood (2003) 101 (11): 4569–4575.

https://doi.org/10.1182/blood-2002-10-3017

Published: 2003

NARROW

Association of High Levels of Free Light Chain and the Presence of Igh Translocations in Multiple Myeloma and Prognostic Implications.

Appraisal of immunoglobulin free light chain as a marker of response

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

A Phase II Study of PS-341 for Patients with High Risk, Newly Diagnosed Multiple Myeloma: A Trial of the Eastern Cooperative Oncology Group (E2A02).

Comparison of Myeloma Cell Gene Expression Profiles Pre and Post Thalidomide - Dexamethasone Therapy Provides Insight into Potential Mechanisms.

SNP Genotypes as Prognostic Factors Associated with Staging in Myeloma: The First Combined SNP Association Analysis of SWOG, ECOG, and MRC Clinical Trials from the Bank on a Cure.

Incidence, Outcomes, and SNP Genotypes Show Different Ethnic Association in Patients with Myeloma, Assessed in SWOG and ECOG Clinical Trials S9321 and E9486: From the Bank on a Cure.

Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM).

Inherited Genetic Variation and the Risk of Developing Venous Thrombosis with Thalidomide Treatment in Myeloma Patients.

Comparison of Newly Diagnosed and Relapsed Refractory Multiple Myeloma Using Transcriptional Profiling of Myeloma Cells.

Gene Expression Profiling of Myeloma Cells at Diagnosis Can Predict Response to Therapy with Thalidomide and Dexamethasone Combination.

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS

Prognostic Value of Syndecan-1 in Multiple Myeloma and its Relationship with Other Prognostic Factors.

Thalidomide Plus Dexamethasone Versus Dexamethasone Alone in Newly Diagnosed Multiple Myeloma (E1A00): Results of a Phase III Trial Coordinated by the Eastern Cooperative Oncology Group.

Associations of DNA Repair Gene Polymorphisms in XRCC1 and ERCC2 with Clinical Outcome in ECOG Trial E9486.

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

Clinical and biologic implications of recurrent genomic aberrations in myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only